en

PRODUCT DETAIL

Triumeq 50 mg/600 mg/300 mg filmom obalené tablety

Code 1459B
MA number EU/1/14/940/001
Product Form: tbl flm 30x50 mg/600 mg/300 mg (fľ.HDPE)
MA Status: E - Valid centralised marketing authorisation
Type of procedure: EU
Therapeutic Class: 42 - CHEMOTHERAPEUTICA (VRATANE TUBERKULOSTATIK)
ATC:
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AR Antivirals for treatment of HIV infections, combinations
J05AR13 Lamivudine, abacavir and dolutegravir
Shelf life: 36
Container: bottle HDPE
Route of admin.: Oral use
Prescription Status: Medicinal product subject to restricted medical prescription.
Legal basis: Article 8(3) application - new active substance
MA issued: 01.09.2014
SmPC + PL: European Medicines Agency's database
Safety feature Yes
Data update: 15.03.2023
eu-flag.png sk-flag.png